Top 5 Drug And Medical Device Developments Of 2018

By Christine Kain, Patrick Reilly, Joseph Price and Isabelle Chammas (January 2, 2019, 2:31 PM EST) -- It's that time of year again — the end of one and beginning of another — when we pause, reflect and look forward to the year ahead. In this retrospective, we consider the past year's legal developments in the drug and medical device sphere, with brief summaries of those we believe to have significant implications for our clients and colleagues. Here are our top five picks for 2018.

The FDA's Proposed 510(k) Overhaul

This past year saw a dramatic increase in mainstream media focus on the medical device industry and the U.S. Food and Drug Administration. This was exemplified in the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!